OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of the adjuvanted Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation amongst adults aged 75 years and older in England, estimated using a test-negative case control study design
Freja Kirsebom, Nick Andrews, Julia Stowe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Freja Kirsebom, Nick Andrews, Julia Stowe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Showing 5 citing articles:
Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023
Eero Poukka, Jori Perälä, Hanna Nohynek, et al.
Eurosurveillance (2024) Vol. 29, Iss. 37
Open Access | Times Cited: 7
Eero Poukka, Jori Perälä, Hanna Nohynek, et al.
Eurosurveillance (2024) Vol. 29, Iss. 37
Open Access | Times Cited: 7
Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study
Freja Kirsebom, Julia Stowe, Jamie Lopez Bernal, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Freja Kirsebom, Julia Stowe, Jamie Lopez Bernal, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2
Eduardo M. Bruch, Shaolong Zhu, Lisa Szymkowicz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Eduardo M. Bruch, Shaolong Zhu, Lisa Szymkowicz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1
Stephanie K. Lathrop, Jordan Clark, Karthik Siram, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Stephanie K. Lathrop, Jordan Clark, Karthik Siram, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
The impact of Covid-19 vaccination in Aotearoa New Zealand: a modelling study
Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, et al.
arXiv (Cornell University) (2024)
Open Access
Samik Datta, Giorgia Vattiato, Oliver J. Maclaren, et al.
arXiv (Cornell University) (2024)
Open Access
